- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Vivanza Biosciences Limited has announced its financial results for the quarter ended June 30, 2025. The consolidated total income from operations was Rs 8.96 crore, with a net profit after tax of Rs 0.09 crore. Standalone total income reached Rs 7.84 crore, reporting a profit after tax of Rs 0.02 crore. The company's equity share capital stands at Rs 4.00 crore, with a basic and diluted earnings per share of Rs 0.02. These figures offer investors a clear overview of the company's recent operational performance.